{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:45:33Z","timestamp":1794329133300,"version":"4.9.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.euroneuro.2015.05.008","type":"journal-article","created":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T13:24:09Z","timestamp":1433597049000},"page":"1631-1636","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Baclofen for alcohol dependence: Relationships between baclofen and alcohol dosing and the occurrence of major sedation"],"prefix":"10.1016","volume":"25","author":[{"given":"Benjamin","family":"Rolland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Labreuche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Duhamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Deheul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Gautier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Auffret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baptiste","family":"Pignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Valin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis","family":"Bordet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Cottencin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2015.05.008_bib1","unstructured":"Agence Fran\u00e7aise du M\u00e9dicament et des produits de sant\u00e9, 2014. Recommandation temporaire d\u05f3utilisation (RTU) pour le baclof\u00e8ne \u2013 Point d\u05f3information Temporary recommendation for use (TRU) for baclofen. Available online at: \u3008http:\/\/ansm.sante.fr\/S-informer\/Actualite\/Une-recommandation-temporaire-d-utilisation-RTU-est-accordee-pour-le-baclofene-Point-d-information\u3009 (accessed 10.03.15)."},{"issue":"4","key":"10.1016\/j.euroneuro.2015.05.008_bib2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/alcalc\/agu016","article-title":"How accurate are blood (or breath) tests for identifying self-reported heavy drinking among people with alcohol dependence?","volume":"49","author":"Bertholet","year":"2014","journal-title":"Alcohol Alcohol."},{"issue":"6","key":"10.1016\/j.euroneuro.2015.05.008_bib3","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/jama.2014.17841","article-title":"Accuracy of smartphone applications and wearable devices for tracking physical activity data","volume":"313","author":"Case","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.euroneuro.2015.05.008_bib4","unstructured":"ClinicalTrials.gov-a. Baclofen for the Treatment of Alcohol Drinkers. \u3008http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01604330?term=bacloville&rank=1\u3009 (accessed 10.03.2015."},{"key":"10.1016\/j.euroneuro.2015.05.008_bib5","unstructured":"ClinicalTrials.gov-b. Efficacy and Safety of Baclofen for Maintenance of Abstinence in Alcohol Dependent Patients. \u3008http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01738282?term=alpadir&rank=1\u3009 (accessed 10.03.2015."},{"issue":"4","key":"10.1016\/j.euroneuro.2015.05.008_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4103\/2229-3485.86879","article-title":"Patient-reported outcomes: a new era in clinical research","volume":"2","author":"Deshpande","year":"2011","journal-title":"Perspect. Clin. Res."},{"issue":"2","key":"10.1016\/j.euroneuro.2015.05.008_bib7","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.euroneuro.2013.09.008","article-title":"Baclofen for alcohol dependence in France: incidence of treated patients and prescription patterns\u2014a cohort study","volume":"24","author":"Dupouy","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.euroneuro.2015.05.008_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1530-0277.2008.00805.x","article-title":"Acute interaction of baclofen in combination with alcohol in heavy social drinkers","volume":"33","author":"Evans","year":"2009","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.euroneuro.2015.05.008_bib9","unstructured":"Food and Drug Administration, 2015. What is a serious adverse event?. Available at: \u3008http:\/\/www.fda.gov\/safety\/medwatch\/howtoreport\/ucm053087.htm\u3009 (accessed 10.03.2015)."},{"issue":"1","key":"10.1016\/j.euroneuro.2015.05.008_bib10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jsat.2008.09.011","article-title":"The impact of loss to follow-up on hypothesis tests of the treatment effect for several statistical methods in substance abuse clinical trials","volume":"37","author":"Hedden","year":"2009","journal-title":"J. Subst. Abuse Treat."},{"issue":"5","key":"10.1016\/j.euroneuro.2015.05.008_bib11","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/bcpt.12344","article-title":"A nationwide register-based survey of baclofen toxicity","volume":"116","author":"Kiel","year":"2015","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.euroneuro.2015.05.008_bib12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4037\/ajcc2005.14.1.61","article-title":"Will adequate sedation assessment include the use of actigraphy in the future?","volume":"14","author":"Lafleur","year":"2005","journal-title":"Am. J. Crit. Care"},{"key":"10.1016\/j.euroneuro.2015.05.008_bib13","author":"M\u00fcller","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.euroneuro.2015.05.008_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.15288\/jsa.1987.48.119","article-title":"The characteristics of alcoholics frequently lost to follow-up","volume":"48","author":"Mackenzie","year":"1987","journal-title":"J. Stud. Alcohol"},{"key":"10.1016\/j.euroneuro.2015.05.008_bib15","unstructured":"National Institute on Alcohol Abuse and Alcoholism. What is \u00ab at-risk \u00bb or \u00ab heavy \u00bb drinking? Available at: \u3008http:\/\/rethinkingdrinking.niaaa.nih.gov\/IsYourDrinkingPatternRisky\/WhatsAtRiskOrHeavyDrinking.asp\u3009 (accessed 10.03.2015)."},{"issue":"6","key":"10.1016\/j.euroneuro.2015.05.008_bib16","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2515\/therapie\/2010073","article-title":"A system of prescriptions without drug approval: example of baclofen","volume":"65","author":"Rolland","year":"2010","journal-title":"Therapie"},{"issue":"4","key":"10.1016\/j.euroneuro.2015.05.008_bib17","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1360-0443.2011.03752.x","article-title":"Alcohol-dependence: the current French craze for baclofen","volume":"107","author":"Rolland","year":"2012","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.euroneuro.2015.05.008_bib18","doi-asserted-by":"crossref","first-page":"e98062","DOI":"10.1371\/journal.pone.0098062","article-title":"Off-label baclofen prescribing practices among French alcohol specialists: results of a national online survey","volume":"9","author":"Rolland","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.euroneuro.2015.05.008_bib19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/YIC.0000000000000054","article-title":"Safety and drinking outcomes among patients with comorbid alcohol dependence and borderline personality disorder treated with high-dose baclofen: a comparative cohort study","volume":"30","author":"Rolland","year":"2015","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.euroneuro.2015.05.008_bib20","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1001\/archneur.1977.00500190056008","article-title":"Baclofen, a new antispastic drug. a controlled, multicenter trial in patients with multiple sclerosis","volume":"34","author":"Sachais","year":"1977","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.euroneuro.2015.05.008_bib21","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1360-0443.1988.tb00485.x","article-title":"Reliability of a timeline method: assessing normal drinkers\u05f3 reports of recent drinking and a comparative evaluation across several populations","volume":"83","author":"Sobell","year":"1988","journal-title":"Br. J. Addict."},{"key":"10.1016\/j.euroneuro.2015.05.008_bib22","unstructured":"Soci\u00e9t\u00e9 Fran\u00e7aise d\u05f3Alcoologie, 2015. Good Practice Recommendation. Alcohol misuse: screening, diagnosis, and treatment. Available at: \u3008http:\/\/www.sfalcoologie.asso.fr\/download\/SFA-GPR-AlcoholMisuse.pdf?PHPSESSID=5b26fb3d20947af67a5f63e5f6689df8\u3009 (accessed 10.03.2015)."},{"issue":"4","key":"10.1016\/j.euroneuro.2015.05.008_bib23","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2307\/2531734","article-title":"Models for longitudinal data: a generalized estimating equation approach","volume":"44","author":"Zeger","year":"1988","journal-title":"Biometrics"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X15001649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X15001649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T03:51:46Z","timestamp":1599105106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X15001649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0924977X15001649"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2015.05.008","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Baclofen for alcohol dependence: Relationships between baclofen and alcohol dosing and the occurrence of major sedation","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2015.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}